Elbrit Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 16-11-2024
- Paid Up Capital ₹ 7.52 M
as on 16-11-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.13 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.00 Cr
as on 16-11-2024
- Revenue 65.60%
(FY 2023)
- Profit 72.82%
(FY 2023)
- Ebitda 87.27%
(FY 2023)
- Net Worth 13.67%
(FY 2023)
- Total Assets 5.74%
(FY 2023)
About Elbrit Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.52 M.
The company currently has active open charges totaling ₹7.13 Cr. The company has closed loans amounting to ₹4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kailasanathan Prakash, Senthilkumar Kailasanathan, and Karukkupalayam Nivedha serve as directors at the Company.
- CIN/LLPIN
U74999TZ2014PTC029965
- Company No.
029965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Erode, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Elbrit Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kailasanathan Prakash  | Managing Director | 18-Jan-2014 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Senthilkumar Kailasanathan | Whole-Time Director | 18-Jan-2014 | Current |
| Karukkupalayam Nivedha | Whole-Time Director | 09-Apr-2021 | Current |
Financial Performance of Elbrit Life Sciences.
Elbrit Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 65.6% increase. The company also saw a substantial improvement in profitability, with a 72.82% increase in profit. The company's net worth Soared by an impressive increase of 13.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elbrit Life Sciences?
In 2023, Elbrit Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Etsu Healthcare Private LimitedActive 4 years 10 monthsKailasanathan Prakash and Senthilkumar Kailasanathan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 May 2024 | ₹3.88 M | Open |
Hdfc Bank Limited Creation Date: 08 Mar 2023 | ₹2.32 M | Open |
Hdfc Bank Limited Creation Date: 21 Nov 2022 | ₹2.01 M | Open |
How Many Employees Work at Elbrit Life Sciences?
Elbrit Life Sciences has a workforce of 213 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elbrit Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elbrit Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
